Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24371181 | 0.78 | SMN1; SMN2 (0.39) | — | |
| SCHEMBL12795992 | 0.70 | FABP3 (0.31) | FABP3FABP4 | |
| SCHEMBL12342530 | 0.70 | FABP3 (0.31) | FABP3FABP4 | |
| SCHEMBL25848618 | 0.67 | NOS3 (0.32) | — | |
| SCHEMBL25848619 | 0.67 | ALDH1A1 (0.31) | FABP3FABP4 | |
| SCHEMBL21565625 | 0.65 | — | — | |
| SCHEMBL18748604 | 0.64 | CHEK1 (0.33) | FABP4 | |
| Hydrogen Peroxide SCHEMBL3267226 | 0.64 | FABP3 (0.52) | FABP3FABP4 | |
| Hydrogen Peroxide SCHEMBL3271571 | 0.64 | FABP3 (0.52) | FABP3FABP4 | |
| Hydrogen Peroxide SCHEMBL11574983 | 0.64 | FABP3 (0.52) | FABP3FABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708369-B2 | Heteroaromatic compounds having activity against RSV | Janssen Sciences Ireland Unlimited Company (IE) | 2023-07-25 | — | — | US | disclosed |
| US-11708369-B2 | Heteroaromatic compounds having activity against RSV | Janssen Sciences Ireland Unlimited Company (IE) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708369-B2 | Heteroaromatic compounds having activity against RSV | MAVS, ZC3HAV1, SARS1 | FABP3 3356/4885FABP4 3999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.